Correlation Between Pfizer and IShares MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and IShares MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and IShares MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and iShares MSCI USA, you can compare the effects of market volatilities on Pfizer and IShares MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of IShares MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and IShares MSCI.

Diversification Opportunities for Pfizer and IShares MSCI

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and IShares is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and iShares MSCI USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares MSCI USA and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with IShares MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares MSCI USA has no effect on the direction of Pfizer i.e., Pfizer and IShares MSCI go up and down completely randomly.

Pair Corralation between Pfizer and IShares MSCI

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the IShares MSCI. In addition to that, Pfizer is 1.97 times more volatile than iShares MSCI USA. It trades about -0.26 of its total potential returns per unit of risk. iShares MSCI USA is currently generating about 0.32 per unit of volatility. If you would invest  9,612  in iShares MSCI USA on August 29, 2024 and sell it today you would earn a total of  581.00  from holding iShares MSCI USA or generate 6.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  iShares MSCI USA

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
iShares MSCI USA 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in iShares MSCI USA are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, IShares MSCI may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pfizer and IShares MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and IShares MSCI

The main advantage of trading using opposite Pfizer and IShares MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, IShares MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares MSCI will offset losses from the drop in IShares MSCI's long position.
The idea behind Pfizer Inc and iShares MSCI USA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance